title: Long-term cortical atrophy after excitotoxic striatal lesion: effects of intrastriatal fetal-striatum grafts and implications for Huntington disease.
abstract: It is not currently clear whether the cortical atrophy observed in Huntington disease (HD) is entirely a direct consequence of the disease or at least partially a secondary consequence of striatal atrophy. This is of major importance for evaluating the possible therapeutic value of intrastriatal fetal-striatum grafts in HD. Cresyl violet-stained sections from rats that had received striatal excitotoxic lesions 1 wk or 4 wk previously showed small and statistically nonsignificant decreases in the thickness of cortical layers V and VI, while series from rats lesioned 12 months previously showed marked decreases in the thickness of the whole cortex (approximately 35% decrease), layer V (approximately 45%-50%) and layer VI (approximately 45%-50%), together with marked neuron loss in these layers. In deep layer V and layer VI, Fluoro-Jade staining showed labeled neurons in animals lesioned 1 wk previously, labeled neurons and astrocytes in animals lesioned 4 wk previously, and practically no labeling in animals lesioned 12 months previously. Intracortical injection of Phaseolus vulgaris leucoagglutinin revealed that corticostriatal fibers were practically absent from the lesioned area of striata lesioned 12 months previously. However, rats that received intrastriatal fetal-striatum grafts shortly after the lesion and were killed 12 months later showed a significant reduction in cortical atrophy, and a large number of labeled corticostriatal fibers surrounding and innervating the graft. In addition, a reduction in the number of Fluoro-Jade-labeled cells in the cortex was already apparent at 3 wk post-grafting. Regardless of whether HD has a primary effect on the cortex, the present results suggest that the striatal degeneration caused by HD contributes markedly to the cortical atrophy, and that intrastriatal grafts may ameliorate this secondary component of the cortical degeneration.
authors.affiliation: Department of Morphological Sciences, Faculty of Medicine, University of Santiago de Compostela, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Muñoz
authors.forename: A
authors.initials: A
authors.lastname: Lopez
authors.forename: H J
authors.initials: HJ
authors.lastname: Caruncho
authors.forename: M J
authors.initials: MJ
authors.lastname: Guerra
authors.forename: J L
authors.initials: JL
authors.lastname: Labandeira-García
mesh_terms: D000818:Animals; D001284:Atrophy; D001927:Brain Diseases / Q000139:chemically induced / Q000473:pathology*; D002540:Cerebral Cortex / Q000473:pathology*; D003342:Corpus Striatum / Q000187:drug effects / Q000196:embryology / Q000473:pathology* / Q000601:surgery*; D005260:Female; D016332:Fetal Tissue Transplantation; D006816:Huntington Disease / Q000601:surgery*; D007051:Ibotenic Acid / Q000494:pharmacology; D009410:Nerve Degeneration / Q000473:pathology / Q000601:surgery; D009498:Neurotoxins / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors
chemical_list: D009498:Neurotoxins; D007051:Ibotenic Acid